Put Options

29 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.36 - $29.54 $83,248 - $127,022
4,300 Added 1.64%
265,700 $5.14 Million
Q2 2024

Aug 15, 2024

BUY
$21.87 - $28.24 $402,408 - $519,616
18,400 Added 7.57%
261,400 $6.79 Million
Q1 2024

May 07, 2024

BUY
$27.21 - $39.48 $1.15 Million - $1.67 Million
42,400 Added 21.14%
243,000 $6.95 Million
Q4 2023

Feb 14, 2024

BUY
$21.2 - $31.03 $2.36 Million - $3.45 Million
111,100 Added 124.13%
200,600 $6.14 Million
Q3 2023

Nov 14, 2023

SELL
$26.2 - $36.08 $982,500 - $1.35 Million
-37,500 Reduced 29.53%
89,500 $2.4 Million
Q2 2023

Aug 11, 2023

BUY
$25.16 - $41.38 $357,272 - $587,596
14,200 Added 12.59%
127,000 $4.53 Million
Q1 2023

May 16, 2023

SELL
$23.68 - $38.51 $1.44 Million - $2.35 Million
-60,900 Reduced 35.06%
112,800 $2.87 Million
Q4 2022

Feb 14, 2023

BUY
$28.0 - $40.56 $795,200 - $1.15 Million
28,400 Added 19.55%
173,700 $7.05 Million
Q3 2022

Nov 14, 2022

SELL
$29.63 - $48.31 $829,640 - $1.35 Million
-28,000 Reduced 16.16%
145,300 $4.8 Million
Q2 2022

Aug 15, 2022

SELL
$27.79 - $50.61 $669,739 - $1.22 Million
-24,100 Reduced 12.21%
173,300 $6.1 Million
Q1 2022

May 16, 2022

SELL
$39.62 - $69.97 $629,958 - $1.11 Million
-15,900 Reduced 7.45%
197,400 $9.08 Million
Q4 2021

Feb 14, 2022

SELL
$58.09 - $82.51 $1.45 Million - $2.05 Million
-24,900 Reduced 10.45%
213,300 $14.1 Million
Q3 2021

Nov 15, 2021

BUY
$58.38 - $84.96 $3.78 Million - $5.5 Million
64,700 Added 37.29%
238,200 $14.9 Million
Q2 2021

Aug 11, 2021

SELL
$62.15 - $90.32 $609,070 - $885,135
-9,800 Reduced 5.35%
173,500 $14.4 Million
Q1 2021

May 17, 2021

SELL
$61.35 - $90.47 $4.79 Million - $7.07 Million
-78,100 Reduced 29.88%
183,300 $12.2 Million
Q4 2020

Feb 16, 2021

SELL
$43.82 - $85.37 $749,322 - $1.46 Million
-17,100 Reduced 6.14%
261,400 $20.1 Million
Q3 2020

Nov 16, 2020

SELL
$33.21 - $51.27 $1.96 Million - $3.02 Million
-59,000 Reduced 17.48%
278,500 $12 Million
Q2 2020

Aug 14, 2020

SELL
$26.12 - $43.27 $57,464 - $95,194
-2,200 Reduced 0.65%
337,500 $14.6 Million
Q1 2020

May 15, 2020

SELL
$20.56 - $63.12 $18,504 - $56,808
-900 Reduced 0.26%
339,700 $9.77 Million
Q4 2019

Feb 14, 2020

BUY
$28.14 - $73.01 $2.53 Million - $6.56 Million
89,900 Added 35.86%
340,600 $21.6 Million
Q3 2019

Nov 14, 2019

SELL
$26.26 - $34.86 $2.64 Million - $3.5 Million
-100,400 Reduced 28.6%
250,700 $7.07 Million
Q2 2019

Aug 14, 2019

BUY
$17.43 - $28.82 $261,450 - $432,300
15,000 Added 4.46%
351,100 $9.3 Million
Q1 2019

May 15, 2019

BUY
$12.05 - $20.18 $1.76 Million - $2.94 Million
145,700 Added 76.52%
336,100 $6.17 Million
Q4 2018

Feb 14, 2019

SELL
$10.74 - $19.7 $489,744 - $898,320
-45,600 Reduced 19.32%
190,400 $2.37 Million
Q3 2018

Nov 14, 2018

SELL
$14.0 - $20.3 $1.01 Million - $1.46 Million
-71,800 Reduced 23.33%
236,000 $4.52 Million
Q2 2018

Aug 14, 2018

BUY
$6.37 - $14.02 $942,123 - $2.07 Million
147,900 Added 92.5%
307,800 $4.19 Million
Q1 2018

May 15, 2018

BUY
$3.72 - $7.64 $323,640 - $664,680
87,000 Added 119.34%
159,900 $1.15 Million
Q4 2017

Feb 14, 2018

BUY
$3.14 - $4.5 $107,388 - $153,900
34,200 Added 88.37%
72,900 $268,000
Q3 2017

Nov 14, 2017

BUY
$1.69 - $4.33 $65,403 - $167,571
38,700
38,700 $168,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.36B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.